Forian Inc. (NASDAQ:FORA - Get Free Report) CEO Max C. Wygod acquired 12,320 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was purchased at an average cost of $2.67 per share, for a total transaction of $32,894.40. Following the acquisition, the chief executive officer now owns 1,324,500 shares in the company, valued at approximately $3,536,415. This trade represents a 0.94 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link.
Forian Stock Performance
Shares of NASDAQ:FORA traded up $0.83 on Monday, hitting $3.59. The company's stock had a trading volume of 146,932 shares, compared to its average volume of 33,186. Forian Inc. has a 12 month low of $1.96 and a 12 month high of $4.15. The stock's 50-day moving average is $2.19 and its two-hundred day moving average is $2.21. The company has a market capitalization of $111.35 million, a price-to-earnings ratio of -39.89 and a beta of 1.06.
Hedge Funds Weigh In On Forian
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Virtu Financial LLC acquired a new stake in shares of Forian in the 4th quarter worth approximately $30,000. Renaissance Technologies LLC raised its holdings in Forian by 48.9% during the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company's stock worth $73,000 after purchasing an additional 11,601 shares in the last quarter. Canton Hathaway LLC lifted its position in Forian by 2.3% in the third quarter. Canton Hathaway LLC now owns 269,650 shares of the company's stock worth $582,000 after purchasing an additional 6,125 shares during the period. Elser Financial Planning Inc bought a new position in Forian during the 4th quarter valued at $1,151,000. Finally, Oracle Investment Management Inc. increased its position in shares of Forian by 0.7% during the 4th quarter. Oracle Investment Management Inc. now owns 1,366,107 shares of the company's stock valued at $2,814,000 after purchasing an additional 10,000 shares during the period. Institutional investors own 19.25% of the company's stock.
Analyst Ratings Changes
Separately, Roth Mkm reiterated a "buy" rating and set a $5.00 price objective on shares of Forian in a research report on Thursday, November 14th.
Get Our Latest Report on FORA
About Forian
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Featured Articles
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
